Sign inJoin waitlistJoin the waitlist

Sara Silbert

Assistant Research Physician · Clinical Center at the National Institutes of Health

Credentials: · · · ·

History

Clinical Center at the National Institutes of Health
Present

Hospice and Palliative Medicine
University of Michigan
2021–2022
Pediatric Hematology Oncology
Children's National Hospital
2018–2021
Pediatrics
McGaw Medical Center of Northwestern University
2015–2018
Tulane University School of Medicine
2011–2015

Research

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
Review · Nature Reviews Clinical Oncology · 2022 · Co-first of 9 authors · 279 citations
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Blood · 2022 · 133 citations
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
Blood · 2025 · First of 81 authors · Corresponding · 37 citations

Nirali Shah
17 papers
HS
Haneen Shalabi
11 papers
Adam Lamble
7 papers
Constance Yuan
7 papers
Hao-Wei Wang
7 papers
Toni Foley
6 papers
Alexander Rankin
4 papers
Alexandra Dreyzin
4 papers
David Stroncek
4 papers
AK
Alexandra Kovach
3 papers
Angela Steineck
3 papers
CO
Chelsea O'Koren
3 papers · 3 as a fellow

Clinical trials

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2031
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
Principal investigator · Completed
National Cancer Institute (NCI)
2023–2025
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Principal investigator · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2022–2029
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
Principal investigator · Completed
National Cancer Institute (NCI)
2021–2024